[ad_1]
Sudarshan Pharma IPO Update: After a gap of a few months, activities have started picking up again in the IPO market. The latest IPO is of Sudarshan Pharma Industries Pvt Ltd SME (Sudarshan Pharma Industries Pvt Ltd SME), which came in the market last week. With less time left to subscribe to it, it is important for investors to know how it is responding in the gray market (Sudarshan Pharma GMP)…
This is the size and price band
Let us tell you that the IPO of Sudarshan Pharma Industries Private Limited SME is of 68,62,400 shares. Only fresh issue of shares are included in this IPO. The size of the company’s IPO is Rs 50.10 crore. The face value of the IPO shares is Rs 10 per unit, while the price band of the IPO has been kept at Rs 71 to 73 per share.
limited time to bid
Sudarshan Pharma’s IPO opened for subscription on Thursday, March 09, last week. For this, bidding can be done till 14 March. This means that there is still 02 more days to subscribe to this IPO. After this, the shares will be allotted on March 17. For investors whose bids are unsuccessful, their refund will start from March 20, while shares will be credited to the demat accounts of successful investors on March 21. Finally, on March 22, the shares of Sudarshan Pharma will be listed on BSE and NSE, after which regular open market trading will start in these shares.
Got response like this
The lot size for this IPO is 1600 shares. Retail investors cannot bid for more than one lot. That is, to subscribe to it, the retail investor will need to invest Rs 1,16,800. Whereas high net worth individuals can bid for two lots. Talking about it so far, it has been subscribed 52 percent in the first two days. The retail segment got the maximum subscription of 67 per cent while the NII segment got 38 per cent subscription.
getting signs of earning so much
As far as the gray market is concerned, currently this IPO is trading with a premium of Rs 4 per share according to the upper price band. If the GMP of Rs 04 is reflected in the open market, then Sudarshan Pharma’s shares can be listed at Rs 77 per unit on March 22. This means that successful bidders can earn around 5.50 per cent with the listing itself, which means that as of now, a return of around Rs 6,500 per lot is possible.
Disclaimer: (The information provided here is for information only. It is important to mention here that investing in the market is subject to market risks. Always take expert advice before investing money as an investor. ABPLive.com It is never advised to invest money here.)
read this also: Do you earn from dividends? This is how you can save TDS
[ad_2]
Source link